{
  "items": [
    {
      "title": "Why Amgen (AMGN) Could Be a Hidden Gem Among Dividend Pharma Stocks in 2025",
      "description": "Amgen Inc. (NASDAQ:AMGN) is included among the 14 Best Pharma Dividend Stocks to Buy in 2025. In 2023, the company finalized its $28 billion acquisition of Horizon Therapeutics, a smaller biotech firm. This move helped broaden Amgen’s product portfolio and reduced its reliance on older drugs like Enbrel, which are expected to weigh on future […]",
      "published_utc": "2025-07-19T09:10:53",
      "source": "Yahoo",
      "url": "https://finnhub.io/api/news?id=5f3165a4956d0faf08161b234e7aa0d27c735f17d9269bbf02cfc52124d42b5f",
      "category": "company",
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related_symbols": [
        "AMGN"
      ],
      "api_source": "finnhub_company",
      "id": 136011966,
      "datetime": 1752887453
    }
  ],
  "metadata": {
    "cached_at": "2025-09-25T08:09:16.108509+00:00",
    "cache_key": "news_846cb06afdc7298c830a88949ff4c49c",
    "count": 1
  }
}